256 related articles for article (PubMed ID: 36674884)
1. Spotlight on P2X7 Receptor PET Imaging: A Bright Target or a Failing Star?
Schmidt S; Isaak A; Junker A
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674884
[TBL] [Abstract][Full Text] [Related]
2. Structure-Activity Relationships and Therapeutic Potential of Purinergic P2X7 Receptor Antagonists.
El Idrissi IG; Podlewska S; Abate C; Bojarski AJ; Lacivita E; Leopoldo M
Curr Med Chem; 2024; 31(11):1361-1403. PubMed ID: 37013427
[TBL] [Abstract][Full Text] [Related]
3. PET imaging of P2X
Beaino W; Janssen B; Kooijman E; Vos R; Schuit RC; O'Brien-Brown J; Kassiou M; van Het Hof B; Vugts DJ; de Vries HE; Windhorst AD
J Neuroinflammation; 2020 Oct; 17(1):300. PubMed ID: 33054803
[TBL] [Abstract][Full Text] [Related]
4. Preclinical Evaluation of a P2X7 Receptor-Selective Radiotracer: PET Studies in a Rat Model with Local Overexpression of the Human P2X7 Receptor and in Nonhuman Primates.
Ory D; Celen S; Gijsbers R; Van Den Haute C; Postnov A; Koole M; Vandeputte C; Andrés JI; Alcazar J; De Angelis M; Langlois X; Bhattacharya A; Schmidt M; Letavic MA; Vanduffel W; Van Laere K; Verbruggen A; Debyser Z; Bormans G
J Nucl Med; 2016 Sep; 57(9):1436-41. PubMed ID: 27199364
[TBL] [Abstract][Full Text] [Related]
5. Purinergic receptors P2Y12R and P2X7R: potential targets for PET imaging of microglia phenotypes in multiple sclerosis.
Beaino W; Janssen B; Kooij G; van der Pol SMA; van Het Hof B; van Horssen J; Windhorst AD; de Vries HE
J Neuroinflammation; 2017 Dec; 14(1):259. PubMed ID: 29273052
[TBL] [Abstract][Full Text] [Related]
6. The P2X7 receptor: A main player in inflammation.
Adinolfi E; Giuliani AL; De Marchi E; Pegoraro A; Orioli E; Di Virgilio F
Biochem Pharmacol; 2018 May; 151():234-244. PubMed ID: 29288626
[TBL] [Abstract][Full Text] [Related]
7. PET Imaging of P2X7 Receptor (P2X7R) for Neuroinflammation with Improved Radiosynthesis of Tracer
Huang G; Qiu Y; Bi L; Wei H; Li G; Li Z; Ye P; Yang M; Shen Y; Liu H; Wang L; Jin H
ACS Chem Neurosci; 2022 Dec; 13(23):3464-3476. PubMed ID: 36441909
[TBL] [Abstract][Full Text] [Related]
8. P2X7 receptor antagonists: a patent review (2010-2015).
Park JH; Kim YC
Expert Opin Ther Pat; 2017 Mar; 27(3):257-267. PubMed ID: 27724045
[TBL] [Abstract][Full Text] [Related]
9. Hetero-aryl bromide precursor fluorine-18 radiosynthesis and preclinical evaluation of a novel positron emission tomography (PET) tracer [
Huang G; Lu X; Qiu Y; Bi L; Ye P; Yang M; Shen Y; Jin H; Han J
Bioorg Med Chem; 2022 Nov; 73():116996. PubMed ID: 36126443
[TBL] [Abstract][Full Text] [Related]
10. Characterization of
Territo PR; Meyer JA; Peters JS; Riley AA; McCarthy BP; Gao M; Wang M; Green MA; Zheng QH; Hutchins GD
J Nucl Med; 2017 Mar; 58(3):458-465. PubMed ID: 27765863
[TBL] [Abstract][Full Text] [Related]
11. The purinergic P2X7 receptor as a potential drug target to combat neuroinflammation in neurodegenerative diseases.
Calzaferri F; Ruiz-Ruiz C; de Diego AMG; de Pascual R; Méndez-López I; Cano-Abad MF; Maneu V; de Los Ríos C; Gandía L; García AG
Med Res Rev; 2020 Nov; 40(6):2427-2465. PubMed ID: 32677086
[TBL] [Abstract][Full Text] [Related]
12. PET Imaging of the P2X7 Ion Channel with a Novel Tracer [
Berdyyeva T; Xia C; Taylor N; He Y; Chen G; Huang C; Zhang W; Kolb H; Letavic M; Bhattacharya A; Szardenings AK
Mol Imaging Biol; 2019 Oct; 21(5):871-878. PubMed ID: 30632003
[TBL] [Abstract][Full Text] [Related]
13. Radioligands targeting purinergic P2X7 receptor.
Zheng QH
Bioorg Med Chem Lett; 2020 Jun; 30(12):127169. PubMed ID: 32273217
[TBL] [Abstract][Full Text] [Related]
14. Purinergic P2X7 Receptor: A Cation Channel Sensitive to Tumor Microenvironment.
Scarpellino G; Genova T; Munaron L
Recent Pat Anticancer Drug Discov; 2019; 14(1):32-38. PubMed ID: 30652649
[TBL] [Abstract][Full Text] [Related]
15. The Coming of Age of the P2X7 Receptor in Diagnostic Medicine.
Di Virgilio F; Vultaggio-Poma V; Falzoni S; Giuliani AL
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298415
[TBL] [Abstract][Full Text] [Related]
16. Preclinical Evaluation and Nonhuman Primate Receptor Occupancy Study of
Kolb HC; Barret O; Bhattacharya A; Chen G; Constantinescu C; Huang C; Letavic M; Tamagnan G; Xia CA; Zhang W; Szardenings AK
J Nucl Med; 2019 Aug; 60(8):1154-1159. PubMed ID: 30733317
[TBL] [Abstract][Full Text] [Related]
17. Immune Response Studies Based on P2X7 Receptors: A Mini-Review.
Deng Y; Zhou M; Zhao X; Xue X; Liao L; Wang J; Li Y
Curr Pharm Des; 2022; 28(12):993-999. PubMed ID: 35100953
[TBL] [Abstract][Full Text] [Related]
18.
Koole M; Schmidt ME; Hijzen A; Ravenstijn P; Vandermeulen C; Van Weehaeghe D; Serdons K; Celen S; Bormans G; Ceusters M; Zhang W; Van Nueten L; Kolb H; de Hoon J; Van Laere K
J Nucl Med; 2019 May; 60(5):683-690. PubMed ID: 30262518
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal Positron Emission Tomography Imaging with P2X7 Receptor-Specific Radioligand
Fu Z; Lin Q; Xu Z; Fu W; Shi D; Cheng Y; Yang T; Liu G; Shi H; Cheng D
ACS Chem Neurosci; 2022 Dec; 13(23):3512-3522. PubMed ID: 36383137
[TBL] [Abstract][Full Text] [Related]
20. P2X7 PET Radioligand
Fu Z; Lin Q; Hu B; Zhang Y; Chen W; Zhu J; Zhao Y; Choi HS; Shi H; Cheng D
J Nucl Med; 2019 Jul; 60(7):930-936. PubMed ID: 30655332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
